This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Zacks.com featured highlights include HCA Healthcare, Hubbell, Ferrari and Vertex
by Zacks Equity Research
HCA Healthcare, Hubbell, Ferrari and Vertex have been highlighted in this Screen of The Week article.
HCA Healthcare Stock Up 18.4% in 3 Months: Can You Afford to Miss Out?
by Zubia Masood
HCA benefits from expanding insurance coverage, rising demand and improving margins.
4 GARP Stocks to Scoop up for Maximum Returns
by Zacks Equity Research
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. HCA, HUBB, RACE and VERX are some stocks that hold promise.
HCA Healthcare (HCA) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
New Strong Buy Stocks for September 12th
by Zacks Equity Research
AFRM, SBSI, LYTS, CM and HCA have been added to the Zacks Rank #1 (Strong Buy) List on September 12, 2024.
Cigna Stock Gains 26% in a Year: What Lies Ahead for Investors?
by Zacks Equity Research
CI benefits from improved premiums resulting from an extensive customer base. Buyouts and adequate operating cash flows are other tailwinds.
2 Sector ETFs & Stocks to Bet on Following August Jobs Data
by Sanghamitra Saha
The U.S. economy added 142, 000 jobs in August 2024, more than a downwardly revised 89, 000 in July but below forecasts of 160, 000.
Are Medical Stocks Lagging HCA Healthcare (HCA) This Year?
by Zacks Equity Research
Here is how HCA Healthcare (HCA) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Zacks.com featured highlights include Vertiv, Charles River Associates, Cabot, Leidos and HCA Healthcare
by Zacks Equity Research
Vertiv, Charles River Associates, Cabot, Leidos and HCA Healthcare are part of the Zacks Screen of the Week article.
Top Stock Reports for Apple, Tesla & NextEra Energy
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Tesla, Inc. (TSLA) and NextEra Energy, Inc. (NEE), as well as two micro-cap stocks Investors Title Company (ITIC) and Autoscope Technologies Corporation (AATC).
Select Medical Agrees to Acquire Valir Rehabilitation Hospital
by Zacks Equity Research
SEM enters a definitive agreement to acquire Valir Rehabilitation Hospital and expand its inpatient rehabilitation footprint in Oklahoma City.
5 Dividend Growth Stocks to Buy in Historically Weak September
by Sweta Killa
Vertiv Holdings, Charles River, Cabot, Leidos Holdings and HCA Healthcare could be solid choices for a historically weak September.
HCA Healthcare (HCA) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Top Medical Stocks to Hedge Against the September Effect
by Shaun Pruitt
Often sought out for defensive protection amid heightened market volatility, medical stocks may be of interest to investors in September which has historically been the most challenging month for stocks.
Centene Stock Rises 29% in a Year: Evaluating the Road Ahead
by Zacks Equity Research
CNC gains from improved premiums and service revenues, acquisitions and adequate operating cash flows.
Scoop up These 4 GARP Stocks to Receive Handsome Returns
by Shilpa Mete
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. HCA, ADBE, WRB and VERX are some stocks that hold promise.
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Here's How Much a $1000 Investment in HCA Healthcare Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Universal Health Services, Inc. (UHS) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Universal Health Services (UHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
New Strong Buy Stocks for August 30th
by Zacks Equity Research
FLUT, GCO, OPRA, SUPV and HCA have been added to the Zacks Rank #1 (Strong Buy) List on August 30, 2024.
Tenet Stock Rises 24.6% in 3 Months: Is This Your Buy Signal?
by Kaibalya Pravo Dey
Despite the recent growth in stock price, THC is trading at a discount compared to the industry average.
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.